Dr. Patrick C. Lee, MD

Dr. Lee practices at Monmouth Medical Center in Long Branch, New Jersey, part of RWJBarnabas Health.

Dr. Lee's NPI, 1356442602, was assigned on September 26, 2006. Dr. Lee graduated from Rutgers R W Johnson Medical School (Cam/New Bruns/Pisc) in 2003. Dr. Lee holds New Jersey license 25MA08003400.

Dr. Lee's primary practice is Monmouth Medical Center, at 300 Second Avenue, Long Branch, NJ 07740 in Monmouth County. The practice phone is (732) 222-5200.

Dr. Lee's primary practice is Monmouth Medical Center in Long Branch, New Jersey, part of RWJBarnabas Health. Dr. Lee is also affiliated with Community Medical Center. The medical group on file is RWJBarnabas Health Medical Group. Dmand AI also links Dr. Lee to 1 more hospital, 2 group practices and clinics, 1 home health agency and 1 medical group, each named with a free account.

Dmand AI tracks the electronic health record (EHR) system at each site where Dr. Lee practices, 6 sites in all. Vendor and product names are available with a free account.

Internal medicine is Dr. Lee's primary specialty in the NPI Registry, under taxonomy code 207RH0000X. The record also lists hematology. Dmand AI has Dr. Lee's licenses on file in 4 states: New Jersey, District of Columbia, Maryland and Virginia.

CMS data shows 2,722 Medicare services from Dr. Lee across 10 procedure codes in 2024, for 671 Medicare patients. Medicare paid $246,128 for them.

CMS counts 671 Medicare patients who saw Dr. Lee in 2024. The largest group is 65 to 74, with 271 patients. 75% of them have high blood pressure, and 75% have high cholesterol. 15% are also on Medicaid. Their average risk score is 2.23, where 1.00 is the Medicare average, so they are sicker than most Medicare patients.

Across all payers, Dmand AI patient panel data puts Dr. Lee's median patient age at 73, with 62% women.

In 2024, Dr. Lee wrote 983 Medicare Part D claims for 207 patients. 55% of them were for generic drugs. CMS names the drug for 772 of them, across 25 drugs with 11 or more claims each, at $2,700,916 in total drug cost. In 2023, CMS named 683 claims across 28 drugs.

CMS publishes a Merit-based Incentive Payment System (MIPS) score of 99 out of 100 for Dr. Lee for performance year 2024, reported through an alternative payment model (APM). Dr. Lee accepts Medicare assignment, so Medicare's approved amount is taken as full payment. CMS lists Dr. Lee as offering telehealth.

Dmand AI links 4 papers to Dr. Lee, published from 2017 to 2020. Dr. Lee's most frequent co-authors are Catherine Wu, MD, Sara B. Fazio, MD and Susan E. Frankl, MD.

CMS Open Payments shows 307 general payments to Dr. Lee from 37 drug and device companies from 2016 to 2025. Food and beverage make up the largest share, 94% of the total. Bristol-Myers Squibb Company paid the most, $734.

Dr. Lee graduated from Rutgers R W Johnson Medical School (Cam/New Bruns/Pisc) in 2003.